These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8149212)

  • 41. Essential blepharospasm and related dystonias.
    Jordan DR; Patrinely JR; Anderson RL; Thiese SM
    Surv Ophthalmol; 1989; 34(2):123-32. PubMed ID: 2686056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion.
    Carruthers J; Stubbs HA
    Can J Neurol Sci; 1987 Feb; 14(1):42-5. PubMed ID: 3815164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of botulinum toxin in ophthalmology].
    Huber A; Meyer M
    Klin Monbl Augenheilkd; 1986 Feb; 188(2):89-94. PubMed ID: 3713087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of facial spasm with botulinum toxin. An interim report.
    Frueh BR; Musch DC
    Ophthalmology; 1986 Jul; 93(7):917-23. PubMed ID: 3763137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin paralysis of the orbicularis oculi muscle. Types and time course of alterations in muscle structure, physiology and lid kinematics.
    Horn AK; Porter JD; Evinger C
    Exp Brain Res; 1993; 96(1):39-53. PubMed ID: 8243582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serial SFEMG studies of orbicularis oculi muscle after the first administration of botulinum toxin.
    Bogucki A
    Eur J Neurol; 1999 Jul; 6(4):461-7. PubMed ID: 10362900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin treatment of blepharospasm.
    Elston JS
    Adv Neurol; 1988; 50():579-81. PubMed ID: 3400511
    [No Abstract]   [Full Text] [Related]  

  • 49. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involuntary eyelid closure after STN-DBS: evidence for different pathophysiological entities.
    Weiss D; Wächter T; Breit S; Jacob SN; Pomper JK; Asmus F; Valls-Solé J; Plewnia C; Gasser T; Gharabaghi A; Krüger R
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):1002-7. PubMed ID: 20562465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of blepharospasm and facial hemispasm by injection of botulinum toxin].
    Saraux H
    J Fr Ophtalmol; 1988; 11(3):237-40. PubMed ID: 3418019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum isn't just a poison anymore. Botulinum toxin in treatment of strabismus and essential blepharospasm.
    Cibis GW; Waeltermann J
    Mo Med; 1985 Mar; 82(3):145-7. PubMed ID: 3974563
    [No Abstract]   [Full Text] [Related]  

  • 53. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
    Price J; Farish S; Taylor H; O'Day J
    Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The role of botulinum toxin in the treatment of essential blepharospasm].
    Safran AB
    Schweiz Rundsch Med Prax; 1990 Nov; 79(48):1512-4. PubMed ID: 2255835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An electromyographic analysis of orbicularis oris and buccinator muscle activity in patients with complete dentures fabricated using two neutral zone techniques--a pilot study.
    Ladha KG; Gill S; Gupta R; Verma M; Gupta M
    J Prosthodont; 2013 Oct; 22(7):566-574. PubMed ID: 23725009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered functional connectivity in blepharospasm/orofacial dystonia.
    Jochim A; Li Y; Gora-Stahlberg G; Mantel T; Berndt M; Castrop F; Dresel C; Haslinger B
    Brain Behav; 2018 Jan; 8(1):e00894. PubMed ID: 29568690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm.
    Dutton JJ; Buckley EG
    Ophthalmology; 1988 Nov; 95(11):1529-34. PubMed ID: 3211461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Blepharospasm; results of treatment with botulin].
    Aramideh M; Devriese PP; Ongerboer de Visser BW; Brans JW; Speelman JD
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1509-12. PubMed ID: 8366939
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.